Helix Expands Drug Discovery Collaboration with AstraZeneca
SAN MATEO, Calif., July 7, 2026 Helix has announced a multi-year strategic agreement with AstraZeneca to accelerate genomic research,...
GLP-1
Advertisement
Vivani Medical Partners with Novo Nordisk on NPM-139
ALAMEDA, Calif., July 7, 2026 Vivani Medical, Inc. has entered into a new strategic agreement with Novo Nordisk to...
Vector Secures Exclusive cGMP Peptide Manufacturing Deal
MEQUON, Wis., July 7, 2026 Vector Science & Therapeutics Corp. has entered into a landmark exclusive licensing and cGMP...
InnoCare Doses First Patient in ICP-B208 ADC Clinical Trial
BEIJING, China, July 6, 2026 InnoCare Pharma has announced a significant milestone in its oncology pipeline with the first...
Ascletis Submits FDA INDs for Next-Generation Obesity Drugs
HONG KONG, July 6, 2026 Ascletis Pharma Inc. has announced the submission of two Investigational New Drug (IND) applications...
Advertisements
Viking Therapeutics Launches Phase 1 Study of VK3019 for Weight Loss
SAN DIEGO, June 24, 2026 Viking Therapeutics (NASDAQ: VKTX) announced the initiation of a Phase 1 clinical trial evaluating...
LIR Shows Successful Needle-Free Delivery of GLP-1 Therapies
VANCOUVER, Canada, June 17, 2026 LIR Life Sciences Corp. announced the successful completion of its comparative preclinical animal study...
Novo Nordisk Secures UK Approval for First Wegovy Weight-Loss Pill
BAGSVÆRD, Denmark, June 11, 2026 Novo Nordisk announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has...
Novartis and Orionis Expand AI-Powered Molecular Glue Alliance
BOSTON, Massachusetts, USA and GHENT, Belgium, June 10, 2026 Orionis Biosciences and Novartis have announced a major multi-year strategic...
Teva Acquires Emalex to Advance Tourette Syndrome Therapy
TEL AVIV, Israel, June 10, 2026 Teva Pharmaceutical Industries Ltd. has completed its acquisition of Emalex Biosciences, strengthening its...
Advertisement
